Jeffrey J. Scherman - May 2, 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Chief Accounting Officer
Signature
/s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact
Stock symbol
NEUE
Transactions as of
May 2, 2024
Transactions value $
$0
Form type
4
Date filed
5/6/2024, 06:18 PM
Previous filing
Mar 20, 2024
Next filing
May 13, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Award $0 +16.5K $0.00 16.5K May 2, 2024 Common Stock 16.5K Direct F1, F2, F3
transaction NEUE Restricted Stock Units Award $0 +50K $0.00 50K May 2, 2024 Common Stock 50K Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 This grant was approved on March 11, 2024 by the Issuer's Compensation and Human Capital Committee as part of the Issuer's annual equity grants, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
F3 These restricted stock units vest in three equal annual installments beginning on March 11, 2025.
F4 This grant was approved on October 11, 2023 by the Issuer's Compensation and Human Capital Committee, subject to shareholder approval of an amendment to the Issuer's Amended and Restated 2021 Omnibus Incentive Plan, which approval was obtained on May 2, 2024.
F5 100% of these restricted stock units vest on October 11, 2026.